These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 26558323)
1. DIRECT-ID: An automated method to identify and quantify conformational variations--application to β2 -adrenergic GPCR. Lakkaraju SK; Lemkul JA; Huang J; MacKerell AD J Comput Chem; 2016 Feb; 37(4):416-25. PubMed ID: 26558323 [TBL] [Abstract][Full Text] [Related]
2. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations. Plazinska A; Kolinski M; Wainer IW; Jozwiak K J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542 [TBL] [Abstract][Full Text] [Related]
3. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. Bhattacharya S; Hall SE; Li H; Vaidehi N Biophys J; 2008 Mar; 94(6):2027-42. PubMed ID: 18065472 [TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor. Goetz A; Lanig H; Gmeiner P; Clark T J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586 [TBL] [Abstract][Full Text] [Related]
5. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579 [TBL] [Abstract][Full Text] [Related]
6. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery. Huber T; Menon S; Sakmar TP Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775 [TBL] [Abstract][Full Text] [Related]
7. Potential Application of Alchemical Free Energy Simulations to Discriminate GPCR Ligand Efficacy. Lee HS; Seok C; Im W J Chem Theory Comput; 2015 Mar; 11(3):1255-66. PubMed ID: 26579772 [TBL] [Abstract][Full Text] [Related]
8. Structural Elements in the Gαs and Gαq C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling. Semack A; Sandhu M; Malik RU; Vaidehi N; Sivaramakrishnan S J Biol Chem; 2016 Aug; 291(34):17929-40. PubMed ID: 27330078 [TBL] [Abstract][Full Text] [Related]
9. Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. West GM; Chien EY; Katritch V; Gatchalian J; Chalmers MJ; Stevens RC; Griffin PR Structure; 2011 Oct; 19(10):1424-32. PubMed ID: 21889352 [TBL] [Abstract][Full Text] [Related]
10. The Val34Met, Thr164Ile and Ser220Cys Polymorphisms of the β2-Adrenergic Receptor and Their Consequences on the Receptor Conformational Features: A Molecular Dynamics Simulation Study. Archala A; Plazinski W; Plazinska A Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628258 [TBL] [Abstract][Full Text] [Related]
11. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics. Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802 [TBL] [Abstract][Full Text] [Related]
12. Probing Activation and Conformational Dynamics of the Vesicle-Reconstituted β Tutkus M; Lundgaard CV; Veshaguri S; Tønnesen A; Hatzakis N; Rasmussen SGF; Stamou D J Phys Chem B; 2024 Mar; 128(9):2124-2133. PubMed ID: 38391238 [TBL] [Abstract][Full Text] [Related]
13. Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor. Chen Y; Fleetwood O; Pérez-Conesa S; Delemotte L J Chem Inf Model; 2021 Dec; 61(12):6024-6037. PubMed ID: 34780174 [TBL] [Abstract][Full Text] [Related]
14. Design of Drug Efficacy Guided by Free Energy Simulations of the β Panel N; Vo DD; Kahlous NA; Hübner H; Tiedt S; Matricon P; Pacalon J; Fleetwood O; Kampen S; Luttens A; Delemotte L; Kihlberg J; Gmeiner P; Carlsson J Angew Chem Int Ed Engl; 2023 May; 62(22):e202218959. PubMed ID: 36914577 [TBL] [Abstract][Full Text] [Related]
15. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics. Plazinska A; Plazinski W; Jozwiak K Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162 [TBL] [Abstract][Full Text] [Related]
16. The dynamic process of β(2)-adrenergic receptor activation. Nygaard R; Zou Y; Dror RO; Mildorf TJ; Arlow DH; Manglik A; Pan AC; Liu CW; Fung JJ; Bokoch MP; Thian FS; Kobilka TS; Shaw DE; Mueller L; Prosser RS; Kobilka BK Cell; 2013 Jan; 152(3):532-42. PubMed ID: 23374348 [TBL] [Abstract][Full Text] [Related]
17. Energy Landscapes Reveal Agonist Control of G Protein-Coupled Receptor Activation via Microswitches. Fleetwood O; Matricon P; Carlsson J; Delemotte L Biochemistry; 2020 Feb; 59(7):880-891. PubMed ID: 31999436 [TBL] [Abstract][Full Text] [Related]
18. State-dependent dynamics of extramembrane domains in the β Nikte SV; Joshi M; Sengupta D Proteins; 2024 Mar; 92(3):317-328. PubMed ID: 37864328 [TBL] [Abstract][Full Text] [Related]
19. Recognition of the ligand-induced spatiotemporal residue pair pattern of β2-adrenergic receptors using 3-D residual networks trained by the time series of protein distance maps. Han M; Lee S; Ha Y; Lee JY Comput Struct Biotechnol J; 2022; 20():6360-6374. PubMed ID: 36420156 [TBL] [Abstract][Full Text] [Related]
20. Multiscale modelling to understand the self-assembly mechanism of human β2-adrenergic receptor in lipid bilayer. Ghosh A; Sonavane U; Joshi R Comput Biol Chem; 2014 Feb; 48():29-39. PubMed ID: 24291490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]